Robin Löving

Robin Löving

Company: Salipro Biotech

Job title: CSO


Salipro DirectMX™ Enables Discovery of Novel Therapeutics Against GPCRs 10:00 am

Introduction to the Salipro DirectMX™ technology How to use the Salipro technology in antibody discovery, structure biology and for development of small molecular compounds The chemokine receptor CXCR4 is a validated oncology target, and the development of new compounds has been hampered by difficulties purifying the native receptor Showcasing Salipro DirectMX™ for CXCR4, its characterization,…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.